A Study of ALRN-6924 for the Prevention of Chemotherapy-induced Side Effects (Chemoprotection)

Clinical trial NCT04022876 · TERMINATED

Trial details

NCT number: NCT04022876
Sponsor: Aileron Therapeutics, Inc.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer Small-cell Lung Cancer

Start date: 2019-09-03
Primary completion: 2022-07-30
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.